Press Releases | Takeda Pharmaceuticals
Learn more about Takeda's latest press releases.
Takeda Delivers Strong Revenue and Profit Growth in FY2022 …
May 11, 2023 · Takeda today announced strong financial results for fiscal year 2022 delivering or exceeding management guidance, driven by the performance of its Growth & Launch Products.
Takeda Pharmaceuticals: Global Homepage
Aug 7, 2024 · Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships To Further Drive Health Impact in 93 Countries
Investor Information | Takeda Pharmaceuticals
Access all Takeda investor-related information including financial reports, earnings, quarterly reports, and IR events.
Takeda and AC Immune Announce Exclusive Option and License …
May 13, 2024 · Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression. AC Immune to receive upfront payment of $100 million upon closing and be eligible for an option exercise fee and additional potential milestones of up to ...
FDA Approves EOHILIA (budesonide oral suspension) | Takeda News
Feb 12, 2024 · FDA Approves Takeda’s EOHILIA (budesonide oral suspension), the First and Only Oral Treatment in the U.S. for Eosinophilic Esophagitis (EoE) February 12, 2024. Share. 12 Weeks of Treatment with EOHILIA May Address Significant Unmet Needs of Patients 11 Years of Age and Older. EoE Is a Chronic Disease That Can Significantly Impact Patients ...
Takeda and Biological E. Announce Collaboration for Dengue …
Feb 26, 2024 · Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per Year by 2030 At the Latest. Addresses the Specific Need to Offer Multi-Dose Vials for National Immunization Programs to Help Protect the Most Vulnerable Populations.
Latest Quarterly Financial Reports | Takeda Investor Relations
View Takeda Pharmaceutical Company Limited's most recent earnings results. Download statements and reports, and listen to earnings announcements.
Financial Statements and Highlights | Takeda Investor Relations
Sep 19, 2024 · Takeda provides annual and quarterly financial highlights, statements, and data for investors. Data are available to download in Excel format.
Takeda Completes Acquisition of Shire, Becoming a Global, Values …
OSAKA, JAPAN, January 8, 2019 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in …